Text size Maddie Meyer / Getty Images Moderna on Thursday lost a patent case that had been almost entirely overlooked as the stock increased due to excitement over the company’s Covid-19 vaccine, which will be tested in a large Phase 3 trial to begin. next week. What the decision issued …
Read More »
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »
As the Covid-19 crisis intensifies in the United States, the fight for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek authorization from the Food and Drug Administration for its Covid-19 vaccine starting in October. Meanwhile, the federal government’s Covid-19 vaccine …
Read More »
Text size It is good to be the Dow. The stock market continues to rise on Wednesday, but some indices are rising more than others. S&P 500 futures are up 1.4%, while Dow Jones Industrial Average futures are up 566 points, or 2.1%, and Nasdaq Composite is up just 0.5%. …
Read More »
Tourists stroll through the center of Rovinj on the Istrian peninsula in the Adriatic Sea on July 4, 2020. Denis Lovrovic / Agence France-Presse / Getty Images European stocks rose Wednesday, and US equity futures also rose as investors accepted positive news about a candidate for the coronavirus vaccine. The …
Read More »